---
url: https://www.servicesaustralia.gov.au/ulcerative-colitis
title: Ulcerative colitis - Health professionals - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-20T21:41:56.028Z
source: servicesaustralia.gov.au
---
# Ulcerative colitis

The PBS subsidises biological medicines for patients with moderate to severe ulcerative colitis.

## on this page

-   [Patient eligibility](#a1)
-   [Section 100 arrangements](#a2)
-   [Treatment specifics](#a3)
-   [Authority applications](#a4)
-   [More information](#a5)

## Patient eligibility

The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with biological medicines under the _National Health Act 1953_, sections 85 and 100 for paediatric or adult patients with moderate to severe ulcerative colitis.

Where the term biological medicine appears in reference to a patient 18 years or older, it refers to:

-   adalimumab
-   etrasimod
-   golimumab
-   infliximab
-   ozanimod
-   tofacitinib
-   upadacitinib
-   ustekinumab
-   vedolizumab.

Where the term biological medicine appears in reference to a patient under the age of 18 years, it refers to:

-   adalimumab
-   infliximab.

Patients must be eligible for the [PBS](/pharmaceutical-benefits-scheme) and meet the relevant restriction criteria.

The [Schedule of Pharmaceutical Benefits](http://www.pbs.gov.au/pbs/home) on the PBS website outlines the restrictions for prescribing biological medicines.

## Section 100 arrangements

### Infliximab IV, ustekinumab IV and vedolizumab IV

These items are only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending either:

-   an approved private hospital
-   a public hospital.

These items aren’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.

## Treatment specifics

To be eligible for PBS-subsidised treatment with biological medicines, patients must be treated by one of the following specialists:

-   gastroenterologist
-   consultant physician (internal medicine specialising in gastroenterology)
-   consultant physician (general medicine specialising in gastroenterology)
-   paediatrician - paediatric patients only
-   specialist paediatric gastroenterologist - paediatric patients only.

## Authority applications

### Adult patients

#### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial authority approval to prescribe PBS-subsidised biological medicines to treat moderate to severe ulcerative colitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ulcerative colitis adult - initial authority application form](/pb127?context=20)
-   relevant attachments.

#### Applying for change or recommencement of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications to change or recommence authority approval to prescribe PBS-subsidised biological medicines to treat moderate to severe ulcerative colitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ulcerative colitis adult - change or recommencement authority application form](/pb245?context=20)
-   relevant attachments.

#### Applying for continuing treatment - excluding infliximab SC

Applications for continuing authority approval to prescribe PBS-subsidised biological medicines to treat moderate to severe ulcerative colitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

After we approve the first application for continuing treatment, subsequent continuing treatments with PBS-subsidised biosimilar brands of biological medicines are Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

#### Applying for continuing treatment - infliximab SC

Continuing PBS-subsidised treatment with infliximab SC is Authority Required (Streamlined). You don’t need authority approval from us for the listed quantities and repeats.

### Paediatric patients

#### Applying for initial treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications for initial approval to prescribe PBS-subsidised biological medicines to treat moderate to severe ulcerative colitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ulcerative colitis paediatric - initial authority application form](/pb215?context=20)
-   relevant attachments.

#### Applying for change or recommencement of treatment

Please note: You don’t need to complete this application in writing when you request [PBS authority online](/apply-for-pbs-authority?context=20#accordion1).

Applications to change or recommence authority approval to prescribe PBS-subsidised adalimumab or infliximab to treat moderate to severe ulcerative colitis can be made:

-   using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20#accordion1)
-   in writing and using [HPOS Form upload](/upload-forms-hpos?context=20)
-   in writing and mailed to [PBS Complex Drugs Programs](/health-professionals-contact-information?context=20#complexdrugs).

All written applications must include:

-   details of the proposed prescription or prescriptions
-   the completed [ulcerative colitis paediatric - change or recommencement authority application form](/pb246?context=20)
-   relevant attachments.

#### Applying for continuing treatment

Applications for continuing authority approval to prescribe PBS-subsidised adalimumab or infliximab to treat moderate to severe ulcerative colitis can be made either:

-   in real time using the [Online PBS Authorities system](/apply-for-pbs-authority?context=20)
-   by calling the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs).

After we approve the first application for continuing treatment, subsequent continuing treatments with PBS-subsidised adalimumab and biosimilar brands of infliximab are Authority Required (Streamlined). You don’t need authority approval from us for the listed quantity and repeats.

## More information

Call the [PBS Complex Drugs Programs enquiry line](/health-professionals-contact-information?context=20#complexdrugs) for more information.

[

Ulcerative colitis toxicity and severity descriptors

Toxicity criteria and severity descriptors for treatments required to be trialled before accessing PBS-subsidised biological medicines to treat ulcerative colitis.


](/ulcerative-colitis-toxicity-and-severity-descriptors?context=20)
